Dl-3-n-butylphthalide ameliorates diabetic foot ulcer by inhibiting apoptosis and promoting angiogenesis

Figure 1 Pharmacological targets of Dl-3-n-butylphthalide in diabetic foot ulcers. A: Twenty-six intersection genes of Dl-3-n-butylphthalide against diabetic foot ulcers; B and C: Protein-protein interaction network of the 19 melatonin targets; D and E: Gene ontology and Kyoto Encyclopedia of genes and genomes enrichment analysis of the 26 Dl-3-n-butylphthalide targets. DFU: Diabetic foot ulcers; NBP: Dl-3-n-butylphthalide; GO: Gene ontology; KEGG: Kyoto Encyclopedia of genes and genomes.